177 E COLORADO BLVD, PASADENA, CA
Market cap: $9.4B (12/18/2025)
Price: $68.16
Reports 2025 Fiscal Year-End Results
Investor Presentation
Files Complaint for Declaratory Judgment Against Pharmaceuticals, Investor Presentation
Material Contracts
Reports Fiscal 2025 Third Quarter Results
Reports Fiscal 2025 Second Quarter Results
Appoints Daniel Apel as Chief Financial Officer
FY 2024
Amended Annual Report
Q3
Q2
Q1
S-3ASR
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Notice of Proposed Sale of Securities
Statement of Changes in Beneficial Ownership
Prospectus filed pursuant to Rule 424(b)(7)